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Background: Malaria and schistosomiasis are endemic and co-exist in the same geographic areas, even co-
infecting the same host. Previous studies have reported that concomitant infection with Schistosoma japonicum
could offer protection against experimental cerebral malaria (ECM) in mice. This study was performed to evaluate
whether alterations in parasite density could alter this protective effect.
Methods: Mice were inoculated with 100 or 200 S. japonicum cercariae followed by infection with high or low
density of Plasmodium berghei ANKA strain eight weeks after the first infection. Then, parasitaemia, survival rate
and blood–brain-barrier (BBB) damage were assessed. Interferon-gamma (IFN-γ), interleukin (IL)-4, IL-5, IL-13,
IL-10, and TGF-β levels were determined in splenocyte supernatants using enzyme-linked immunosorbent assay
(ELISA). Cell surface/intracellular staining and flow cytometry were used to analyse the level of CD4+/CD8+ T cells,
CD4+CD25+Foxp3+ Tregs, IL-10-secreting Tregs, and IL-10+Foxp3−CD4+ T cells in the spleen, and CD4+/CD8+ T
cells infiltrating the brain.
Results: Co-infection with low density P. berghei and increased S. japonicum cercariae significantly increased the
levels of IL-4, IL-5, IL-13, TGF-β and Tregs, but significantly decreased the levels of IFN-γ and the percentage of
CD4+ T cells and CD8+ T cells in the spleen and CD8+ T cell infiltration in the brain. Increased worm loads also
significantly decreased mortality and BBB impairment during ECM. When challenged with higher numbers of
P. berghei and increased cercariae, the observed cytokine changes were not statistically significant. The corresponding
ECM mortality and BBB impairment also remained unchanged.
Conclusions: This study demonstrates that protection for ECM depends on the numbers of the parasites, S. japonicum
and P. berghei, during co-infection. Alterations in the regulatory response appear to play a key role in this
adaptation.
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Malaria, caused by the infection of parasites belonging
to Plasmodium species, is a major health problem for
humans in many tropical regions of the world. This dev-
astating disease kills more than one million children
each year [1]. Specifically, cerebral malaria (CM) is one* Correspondence: ymcao@mail.cmu.edu.cn
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tion and a major cause of death among young children
in sub-Saharan Africa [2]. Precise mechanisms of CM
onset are still incompletely understood as multiple fac-
tors including both host and pathogen determinants are
involved in the pathogenesis [3]. Overall, it is considered
that the sequestration of parasitized red blood cells
(pRBCs) in cerebral microvasculature contributes to vessel
occlusion, hypoxia, endothelial activation and blood–
brain-barrier (BBB) dysfunction [4-6].td. This is an Open Access article distributed under the terms of the Creative
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sults from a predominant Th1 response. Besides, a num-
ber of pro-inflammatory cytokines, including IFN-γ and
relatively lower levels of anti-inflammatory cytokines,
such as IL-10 were recorded in individuals with severe
malaria [7,8]. It is generally considered that a proper bal-
ance between pro- and anti-inflammatory molecules is
essential to control the pathogenesis of severe malaria
[9]. While lack of an initial inflammatory stage may lead
to increased parasite proliferation, an uncontrolled in-
flammatory response may lead to severe immunopathol-
ogy [10]. In this molecular balance, CD4+CD25+Foxp3+
regulatory T cells (Tregs) play a critical role. A previous
report demonstrated that Tregs are required to limit
pro-inflammatory immune responses in BALB/c mice to
prevent experimental cerebral malaria (ECM) during
secondary infections [11]. It has also been confirmed
that the occurrence of Tregs during Plasmodium berghei
ANKA infection is negatively associated with the pro-
duction of IFN-γ [12]. Induced and/or activated Tregs
may be beneficial to the vertebrate host because it
down-regulates the inflammatory response and thereby
prevents immune-mediated pathology.
Since helminths and malarial parasites share the same
geographical distribution, they are known to infect the
same vertebrate host population [13]. Therefore, it is im-
portant to elucidate the immune mechanisms underlying
the co-infection of these parasites. Both malaria and hel-
minthiasis induce strong immune responses affecting
the Th1/Th2 balance [13,14]. In a previous study, it was
documented that pre-existing Schistosoma japonicum in-
fection strengthened the Tregs-associated Th2 response
to malaria infection and this Th2 response played an im-
portant role in protecting against ECM pathology [15].
The current study was designed to evaluate whether
parasite density during co-infections modulated this pro-
tective effect that may reveal a parasite threshold for
causing ECM.
Methods
All experimental protocols in the current study were
reviewed and approved by the Medical University Insti-
tute of Medical Research Animal Ethics Committee in
China.
Mice, parasites and experimental infection
Female C57BL/6 mice (four weeks old) were purchased
from Beijing Animal Institute (Beijing, China) and main-
tained in individual ventilated cages in the animal facility
at China Medical University. Mice were provided heat-
sterilized food and distilled water ad libitum. C57BL/6
mice were selected as models in the current study be-
cause they showed high susceptibility to ECM due to
their pro-inflammatory/Th1 predisposition.The S. japonicum strain was obtained from Jiangsu In-
stitute of Parasitic Diseases (Wuxi, China). Plasmodium
berghei ANKA strain (clone 1.49 L) was provided by Dr.
Motomi Torii at the Department of Molecular Parasit-
ology, Ehime University Graduate School of Medicine,
Ehime, Japan. Parasite stabilates were stored at -80°C.
To obtain experimental inoculum of P. berghei, parasit-
ized red blood cells (pRBCs) were sequentially passed
through three homologous donor mice.
Infections were initiated in mice that were five weeks
old. First, mice were infected percutaneously with 100 or
200 S. japonicum cercariae and eight weeks later mice in
both groups were infected with higher dose (1 × 106) or
lower dose (1 × 105) of P. berghei pRBCs. Control mice
were infected with only P. berghei pRBCs or S. japoni-
cum cercariae. Each group had 40 mice. The animals
were euthanized one, three, five and eight days post-P.
berghei infection for evaluation.
Confirmation of helminth infection
Helminth infection was confirmed by the presence of
worms and liver granulomas upon necropsy. Worms
were obtained by portal perfusion as described previ-
ously [16], and livers were examined for the presence of
granulomas under a stereomicroscope.
Malaria parasitaemia, survival rates and disease
assessment
Parasitaemia was determined by staining thin blood
smears from mice tails with Giemsa and observation
under light microscopy. Slides were coded and pRBCs
were counted microscopically in at least five microscopic
fields, each containing approximately 300 cells.
Every day post-P. berghei infection, mice were monitored
for mortality. Clinical ECM was also assessed and was con-
firmed if at least four of the following signs were observed
[12]: ruffled fur, hunching, wobbly gait, limb paralysis, con-
vulsions, or coma. Each sign was given a score of 1. Animals
with scores ≥4 were considered to have severe ECM.
Spleen cell culture
Spleen cell culture was prepared as previously described
[12,17]. Briefly, spleens from infected mice were aseptic-
ally removed and pressed individually through a sterile
fine-wire mesh along with 10 ml RPMI-1640 (Life Tech-
nologies, Shanghai, China) supplemented with 5% heat-
inactivated fetal calf serum (FCS; Hyclone Laboratories,
Inc., South Logan, Utah, USA), 25 mM Hepes (Life Tech-
nologies), 0.12% gentamicin (Schering-Plough, Kenny
Worth, New Jersey, USA), and 2 mM glutamine (Life
Technologies). Cell suspensions were centrifuged at 350 g
for 10 min at room temperature (RT). Erythrocytes were
lysed in cold 0.17 M NH4Cl and the cells were washed
twice in fresh medium. Viability of the spleen cells
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revealed >90% cell survival. Spleen cells were adjusted
to a final concentration of 107 cells/ml in RPMI-1640
supplemented with 10% heat-inactivated FCS. Ali-
quots (500 μl/well) of the cell suspension were incu-
bated in 24-well flat bottom culture plates (Falcon®,
Corning Life Sciences, CA, USA) in triplicate for
48 hrs at 37°C in a humidified incubator with 5% CO2.
The plates were then centrifuged at 350 g for 10 min
at RT and the supernatants were collected and stored
at −80°C until assayed for cytokine levels.
Cytokine analysis
The levels of cytokines such as IFN-γ, IL-4, IL-5, IL-13,
IL-10, and TGF-β in the splenocyte supernatants from
infected mice were measured using commercial enzyme-
linked immunosorbent assay (ELISA) kits according to
the manufacturer’s instructions (R&D Systems, Minneapolis,
MN, USA). All assays were performed in a microtitre plate
reader and the absorbance was recorded at 450 nm. Cyto-
kine concentrations in samples were calculated based on
standard curves generated using recombinant cytokines.
Cell surface/intracytoplasmic staining and flow cytometry
From each experimental group, five or six mice were
sacrificed at the indicated time points for flow cytome-
try. Spleen cells were collected from C57BL/6 mice post
infection (pi). Cell concentration was then adjusted to
2 × 106/ml, followed by stimulation with plate-bound
anti-mouse CD3 (1 μg/ml) and anti-mouse CD28
(0.2 μg/ml) together with Golgi Stop (BD Bioscience,
Cat no 554724) for 4 hrs. After continued co-culture at
37°C for 4 hrs, cells were washed with 3% FCS and re-
suspended in 100 μl of 3% FCS followed by incubation
with APC-conjugated anti-mouse-CD3, FITC-conjugated
anti-mouse CD4, PerCP-Cy5.5-conjugated anti-mouse
CD8 or PerCP-Cy5.5-conjugated anti-mouse CD25 (clone
3C7) for surface staining. The cells were then fixed,
permeabilized and intracytoplasmic staining was per-
formed using APC-conjugated anti-Foxp3 (clone FJK16s)
or PE-conjugated anti-IL-10 (clone JES5-16E3). FITC-
conjugated rat IgG2b was used as the isotype control.
To determine the migration of CD4+ and CD8+ T cells
into the brain, mononuclear cells were isolated from the
brains on day 6 pi. A single-cell suspension was obtained
by homogenizing the tissues in 5 ml of RPMI 1640 con-
taining 100 U/ml IV collagenase (Invitrogen, USA), and
incubating at 42°C for 45 min. Cells were centrifuged at
300 g for 10 min, resuspended in 30% Percoll in PBS
(Sigma), layered on 70% Percoll, and centrifuged at
515 g for 30 min at RT. Cells at the interface were iso-
lated, washed twice, resuspended in PBS, and labeled
with the following antibodies: FITC-anti-CD4, PerCP-
Cy5.5-anti-CD8 (clone 53–6.7), or APC-anti-CD3 (clone145-2C11) by incubating at 4°C for 30 min. After wash-
ing twice in PBS, flow cytometric analysis was performed
using a FACS Calibur, and data were analysed with the
FlowJo software.
Assessment of BBB impairment
A 2% Evans blue dye was prepared with Evans blue pow-
der (Sigma-Aldrich, St Louis, USA) and PBS, followed
by filtration and sterilization. Mice were injected intra-
venously with 200 μl of 2% Evans blue on day 6 pi. The
animals were then sacrificed 1 hr later and brains were
isolated to evaluate vascular leakage of the dye into the
brain parenchyma. After image documentation, brain tis-
sues were weighed and placed in formamide for 48 hrs
at 37°C to extract Evans blue. Aliquots (100 μl) of this
solution were analysed on a microtitre plate. Absorbance
was measured at 620 nm on an ELISA reader and com-
pared to a standard curve [3]. Concentration of Evans blue
was expressed as μg Evans blue per gram brain tissue.
Statistical analysis
Data were analysed using Prism (GraphPad, La Jolla,
CA, USA). Differences in survival was analysed using a
Log-rank (Mantel-Cox) Test. Differences between multiple
means were compared by one-way ANOVA, Tamhane’s
T2 test or Bonferroni test when the variance was hetero-
geneous or homogeneous, respectively. All tests were con-
sidered significant when P < 0.05.
Results
Schistosoma japonicum-mono-infection
All control mice infected with only 100 or 200 S. japo-
nicum cercariae survived until day 75 post infection
(> 10 weeks) after which they were sacrificed. Necropsy
was performed and the results confirmed the existence of
helminth infection in both groups. The levels of associated
cytokines on day 56 (8 weeks) post infection indicated
high Th1/Th2 levels just before the secondary infection
with P. berghei (Figure 1). These results indicated that S.
japonicum infection was in prime when secondary P. ber-
ghei infections were experimentally induced on week 8
post S. japonicum infection. In addition, previous studies
[18] confirmed that responses to Schistosoma infections
were highly Th2 polarized following the onset of egg pro-
duction around week 6. In the current study, S. japonicum
infection on week 8 was primed for a Th2 response.
Plasmodium berghei- Schistosoma japonicum-co-infection
To evaluate the impact of parasite density in offering
protection against the onset of ECM during co-infection,
two schemes were included with two different densities
of both parasites, S. japonicum and P. berghei. Because
mice in the S. japonicum-mono-infected group received
no additional treatment during the co-infection period,
Figure 1 Levels of splenic IFN-γ, IL-4, IL-5, IL-13 and IL-10 in C57BL/6 mice infected with 100 (A) or 200 (B) S. japonicum cercariae.
Splenocytes were isolated from mice on day 56 post-S. japonicum infection and cultured to measure indicated cytokine levels using ELISA. Bars
represent mean values ± SD. n = 5-6 mice per group. Results are representative of three independent experiments.
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(data not shown).
Parasitaemia and survival rate
Malaria parasitaemia and mortality were monitored in
mice in the co-infection-100c and co-infection-200c
groups, and challenged with 1 × 106 P. berghei (Figure 2A)
or by 1 × 105 P. berghei (Figure 2B). In general, all mice
showed increasing parasitaemia during the course of P.
berghei infection. Among the groups, increasing worm
loads resulted in a higher level of parasitaemia on day 4
and 5 pi, or day 4 pi when challenged with higher or lower
density of P. berghei, respectively. Between days 6 and 8,
which is the period of susceptibility to ECM, most mice
presented clinical signs of ECM and subsequently died.
Mice in the co-infection-200c group showed a signifi-
cantly higher survival rate than the co-infection-100c mice
group, when challenged with low density of P. berghei.
However, the difference was not significant when co-
infected with a higher level of P. berghei.
Cytokine concentrations
To evaluate the relationship between the levels of pro-
(IFN-γ) and anti-inflammatory (IL-4, IL-5, and IL-13)
cytokines, and to assess cytokines involved in the regula-
tory responses (IL-10 and TGF-β) in the co-infected and
P. berghei-mono-infected mice, cytokine levels in the su-
pernatants of cultured splenocytes from mice in all
groups were measured by ELISA. When infected with
higher levels of P. berghei all cytokines including IFN-γ,
IL-4, IL-5, IL-13, IL-10, and TGF-β increased immedi-
ately post-P. berghei infection, peaking on day 5 pi and
then declining on day 8 pi (Figure 3A). Compared to
P. berghei-mono, mice in the co-infection-100c group
had significantly lower levels of IFN-γ on days 5 and 8
pi and higher levels of IL-4, IL-5, IL-13 and TGF-β on days
3, 5, and 8 pi, while no significant changes in IL-10 levels
were observed between the two groups. A comparisonbetween the co-infection-200c and co-infection-100c mice
showed no significant difference among all pro- and anti-
inflammatory cytokines measured. When challenged with
lower density of P. berghei, the changes in cytokine levels
over time were similar to those infected with high density
of P. berghei (Figure 3B). Besides, co-infected mice showed
significantly lower levels of IFN-γ and higher levels of IL-4,
IL-5, IL-13, and TGF-β when compared to mice in P.
berghei-mono group. Between the co-infection-200c and
co-infection-100c groups, these cytokine changes were
significant.
The kinetics of T cells population assessed by flow cy-
tometry revealed that both splenic CD4+ and CD8+ T
cells expanded during the course of P. berghei infection
(Figure 4). In the two different S. japonica schemes,
mice in the co-infection-100c group had significantly
lower levels of CD4+ and CD8+ T cells on days 3, 5 and
8 pi when compared to P. berghei-mono group. Interest-
ingly, these differences were observed only when chal-
lenged with lower density of P. berghei when made
comparisons between the co-infection-200c and co-
infection-100c groups. The kinetics of Tregs in both ex-
perimental schemes was also evaluated (Figure 4). Both
IL-10-secreting Tregs, and IL-10 producing Foxp3−CD4+
T cells increased when challenged with higher (Figure 4A)
or lower (Figure 4B) levels of P. berghei, peaking on
day 5 pi and declining on day 8 pi. Among the two ex-
perimental schemes, the co-infection-100c group showed
significantly higher levels of Tregs on days 5 and 8 pi
when compared to P. berghei-mono group. Between the
co-infection-200c and co-infection-100c groups, a signifi-
cant change in this cytokine was present only when
challenged with lower levels of P. berghei. In both experi-
ments, no significant changes were observed in IL-10-
secreting-Tregs and IL-10+Foxp3−CD4+ T cells.
To determine whether parasite dosage affected the mi-
gration and accumulation of T cells in the brains of S.
japonicum-P. berghei-co-infected mice, mononuclear
Figure 2 Parasitaemia and survival rate of C57BL/6 mice co-infected with 100 or 200 S. japonicum cercariae and 1 × 106 (A) or 1 × 105
(B) P. berghei pRBCs after eight weeks. Intensities of S. japonicum cercariae in each panel are indicated as co-infection-200c and co-infection-
100c, respectively. Mice infected with only P. berghei are indicated as P. berghei-mono. Malaria parasitaemia was monitored every day by staining
blood samples from infected mice with Giemsa. Data are represented as mean ± SD. Rectangle boxes indicate periods susceptible to ECM.
Significant differences between the groups in parasitaemia were determined by one-way ANOVA and survival was analysed using a Log-rank
(Mantel-Cox) Test. #indicates P < 0.01. n = 5–6 mice per group. Results are representative of three independent experiments.
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tion of CD4+ (Figure 5A)and CD8+ (Figure 5B) T cells.
Compared to P. berghei-mono-infected mice, those in
the co-infection-100c group recorded a significantly
lower CD8+ T cell accumulation when challenged with
high or low density of P. berghei. In contrast, when com-
pared between co-infection-200c and co-infection-100c
mice, such significant change was present only when
challenged with low density of P. berghei.
BBB damage assessment
One of the hallmarks of CM is the damage of BBB integrity,
which was analysed in all experiments both qualitatively
and quantitatively. When compared to P. berghei-mono-
infected mice, those co-infected with higher or lower dens-
ities of P. berghei along with S. japonicum displayed weak
staining. A representative result in Figure 5C shows brains
of mice challenged with 1 × 106 P. berghei ranging in color
from dark blue, moderate blue, faint blue and unstained
brain in P. berghei-mono, co-infection-100c, co-infection-
200c, and normal control mice, respectively. In addition,
colorimetric analysis of co-infected mice also showed sig-
nificantly lower mass ratio of Evans blue/brain tissue than
P. berghei-mono-infected mice. However, a comparisonbetween co-infection-200c and co-infection-100c mice re-
vealed that the significance was present only in those chal-
lenged with low density of P. berghei (Figure 5D).
Discussion
Epidemiological studies on malaria and schistosomiasis
suggest common immune responses to co-infections in
people living in areas where these diseases are co-endemic
[19]. A previous study documented the existence of shared
antigens in the pathogens and cross-reactive antibodies to
different components of the two parasites [20]. It is well
known that Schistosoma infections have potent immuno-
modulatory effects on their hosts based on their anti-
inflammatory effect, which dampens IFN-γ responses and
switches immune responses toward a Th2 type response
through Tregs [10]. During the past decade, many studies
examined the impact of malaria co-infection with schisto-
somiasis although the results were contradicting. In a
Plasmodium yoelii murine model, co-existing Schistosoma
mansoni infection appeared to increase parasitaemia and
the lethal disease [21]. Waknine-Grinberg et al. [22] and
Bucher et al. [9] demonstrated that S. mansoni co-infected
with P. berghei offered protection against cerebral malaria,
while Lyke et al. [23] and Thigpen et al. [24] showed that
Figure 3 (See legend on next page.)
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Figure 3 Levels of splenic IFN-γ, IL-4, IL-5, IL-13, IL-10, and TGF-β in C57BL/6 mice co-infected with 100 or 200 S. japonicum cercariae
and 1 × 106 (A) or 1 × 105 (B) P.berghei pRBCs after eight weeks. Intensities of S. japonicum cercariae in each panel are indicated as
co-infection-200c and co-infection-100c, respectively. Mice infected with only P. berghei are indicated as P. berghei-mono. Splenocytes were
isolated from mice on days 1, 3, 5, 8 post-P. berghei infection and cultured to measure indicated cytokine levels using ELISA. Bars represent mean
values ± SD. Significant differences in cytokine levels over time and between indicated groups were determined by one-way ANOVA with
*indicating P < 0.05 and #indicating P < 0.01. n = 5-6 mice per group. Results are representative of three independent experiments.
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Plasmodium parasitaemia, combined with increased
IFN-γ and IL-2 during malaria infection. Thus, S. hae-
matobium infection appears to increase the inflamma-
tory response following malaria infection. Moreover, a
study in Thailand documented that Plasmodium falcip-
arum malaria increased in helminth-infected patients
but reduced cerebral malaria and acute renal failure
[25]. These divergent results may be caused by the use
of different Plasmodium strains co-infected with differ-
ent Schistosoma strains, each in various quantities with
different but overlapping influences on immunity [25].
Currently, S. mansoni is the most widely used Schisto-
soma species to evaluate host immune responses [26]
and only a few studies have used S. japonicum to create
a Schistosoma-Plasmodium-co-infection murine model.
A previous study demonstrated that S. japonicum co-
infection could offer protection against cerebral malaria
by enhancing Th2 responses [15]. The current study fur-
ther examined the interactions between S. japonicum
and P. berghei when the worm loads and Plasmodium
densities were changed by evaluating several critical fac-
tors, such as malaria parasitaemia, Th1/Th2 responses,
and the regulatory responses.
Plasmodium parasitaemia could be affected by multiple
factors, including the dose of parasites infecting a host,
immunity status of the host, and additional antigen inter-
ference, such as concomitant infection with Schistosoma.
In general, it is believed that concomitant infection with
Schistosoma could increase Plasmodium parasitaemia,
which is consistent with results from the current study.
This study also indicated that increasing the cercariae load
also increased the parasitaemia in co-infected mice. The
likely cause for this is the enhanced Th2 response when
increasing the worm load. The associated Th1/Th2 cyto-
kine analysis in future investigations will offer additional
insights into the regulation of this mechanism.
Previous reports [22] have indicated the role of cyto-
kines IFN-γ, IL-4, IL-5, and IL-13 in response to co-
infections with Plasmodium and Schistosoma. Wang et al.
also documented an increase in Th2 cytokines and decline
in Th1 cytokines concomitant with S. japonicum infection
[15]. Existing evidence suggests that increased worm load
could lead to a more polarized Th2 response during Schis-
tosoma-Plasmodium-co-infection. Yet this occurred only
when the density of Plasmodium was low suggesting thatthe previous speculation of the immunomodulatory mech-
anism may be an oversimplification and may not apply at
least for co-infections with worms and malaria parasites.
Immune response during co-infections is complex largely
due to an interactive effect between the responses trig-
gered by two parasites. Schistosoma infection could down-
regulate Th1 responses induced by Plasmodium infection
although this effect may be suppressed when Plasmo-
dium-induced Th1 response is too strong, as evidence in
this study in mice challenged with high density of P. ber-
ghei. Taken together, these findings indicate that increased
worm loads may lead to a decrease in Th1 response with
concomitant Plasmodium infection, while the reduction
magnitude may depend on Plasmodium density.
Another hypothesis in the present study is that regula-
tory responses, including Tregs, IL-10 and TGF-β, play a
role in the immune responses of the vertebrate host dur-
ing co-infections. Previous studies have reported the in-
volvement of Tregs in the immune responses to both
malaria [11,12] and schistosomiasis [27] infections. In
vitro culture experiments have suggested that IL-10 and
TGF-β are major cytokines that drive the induction and
expansion of Tregs [28]. Results of the current study in-
dicate that TGF-β plays a major role in the induction
of Tregs mediated anti-inflammatory responses as ev-
idenced by a significant increase in TGF-β levels in
co-infected mice while the IL-10 levels remained un-
changed. In general, Tregs is known to play two major
roles in host immunity. First, Tregs could block T cell-
mediated clearance of malaria parasites, facilitating an in-
crease in parasitaemia. Second, Tregs could potentially
play a beneficial role in preventing immunopathology dur-
ing the infection [29]. In a previous study [29], Ashraful
et al. documented a Tregs-induced reduction in T cell-
mediated parasite tissue sequestration in a mouse mal-
aria model, thereby limiting malaria-induced immune
pathology. The study reported that total depletion of
natural Tregs could not offer protection against ECM.
In contrast, sufficient expansion of Tregs via IL-2Jc
during P. berghei infection could suppress normal
pathogenic T cell responses and prevented ECM. Pre-
existing S. japonicum infection has been also reported
to increase the absolute number of Tregs in spleno-
cytes [15]. The findings of the current study corrobor-
ate these data and further extend the occurrence of
increased Tregs numbers to increased worm loads during
Figure 4 The percentage of splenic CD4+/CD8+ T cells, and the absolutely numbers of CD4+CD25+Foxp3+Tregs, IL-10-secreting Tregs
and IL-10+Foxp3−CD4+ T cells in C57BL/6 mice co-infected with 100 or 200 S. japonicum cercariae and 1 × 106 (A) or 1 × 105 (B) P.
berghei pRBCs eight weeks later. Intensities of S. japonicum cercariae in each panel are indicated as co-infection-200c and co-infection-100c,
respectively. Mice infected with only P. berghei are indicated as P. berghei-mono. Mice were dissected on days 1, 3, 5, 8 post-P. berghei infection to
obtain the respective cell counts. Bars represent the mean values ± SD. One-way ANOVA was performed to compare values between indicated
groups with *indicating P < 0.05 and #indicating P < 0.01. n = 5–6 mice per group. FACS plots were used to show the cell populations and the
gating strategy.
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Figure 5 The percentage of CD4+ (A) and CD8+ (B) T cells in the brain of C57BL/6 mice, which were co-infected with 100 or 200 S.
japonicum cercariae and 1 × 106 or 1 × 105 P. berghei pRBCs eight weeks later. Intensities of S. japonicum cercariae in each panel are
indicated as co-infection-200c and co-infection-100c, respectively. Mice infected with only P. berghei are indicated as P. berghei-mono. Mice were
dissected on days 6 post-P. berghei infection to obtain the respective cell counts. In addition, BBB damage was evaluated by the blue discoloration of
the Evans blue stained brain tissues. Representative examples for P. berghei-mono-infection, co-infection-100c, co-infection-200c, and normal controls
are shown in panel (C). Quantification of Evans blue extravasation in formamide was measured as absorbance at 620 nm (D). Bars represent the mean
values ± SD. One-way ANOVA was performed to compare values between indicated groups with *indicating P < 0.05 and #indicating P < 0.01. n = 5–6
mice per group. FACS plots were used to show the cell populations and the gating strategy.
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mune response could indeed offer more protection
against ECM.
Based on previous pathophysiological manifestations,
C57BL/6 mice animal models were highly susceptible to
P. berghei infections. In this study, BBB impairment was
chosen for analysis rather than brain histopathology be-
cause of the ease in visualizing cerebral damage by
naked eyes without the need for microscopes or any
other complicated instrumentation. In addition, quanti-
tative analysis by colorimetric modality provided more
precise evidence to evaluate ECM impairment. These re-
sults showed that increasing worm loads concomitant
with low density of P. berghei resulted in higher protec-
tion against ECM. A previous study [29] established that
INF-γ was required for the development of ECM during
P. berghei infection in C57BL/6 mice. Here, INF-γ-
producing CD4+ T cells, but not innate or CD8+ T cells
promoted the development of ECM. The cerebral path-
ology during ECM is an IFN-γ-dependent process as evi-
denced by the complete resistance of the IFN-γ deficient
mice to ECM [30]. IFN-γ is responsible for the inductionof chemokines CXCL9 and CXCL10 during ECM [31],
which subsequently recruit CD4+ and CD8+ T cells to
the brain [32,33], with the latter one worked as the key
role for pathogenicity. The current study also showed
the expansion of splenic CD4+ and CD8+ T cells during
the course of P. berghei infection although the pheno-
types of T cells infiltration in the brain differed between
the co-infected and P. berghei-mono-infected mice; CD8+
T cells were lower in co-infected mice when compared to
P. berghei-mono-infected mice, and increasing the worm
load during the co-infection further turned down the
levels of CD8+ T cells. These results were consistent with
the associated ECM survival data.
Among the various studies performed to explore the
immunomodulatory mechanisms during malaria co-
infection, most have been on infections with different
Schistosoma species and various Plasmodium species,
which is similar to the current study but thus far none
had addressed the effect of parasite densities during co-
infection. Waknine-Grinberg et al. [22] performed a
study and showed that increased cercarial dose provided
more protection against ECM, which is consistent with
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and associated cytokines investigated in the current
study offer more insights into the immune responses
during such infections. This study clearly demonstrates
that both the Schistosoma and Plasmodium densities
play major roles in modulating the immune responses of
the vertebrate host during co-infection. These findings
offer useful insights to understand the complex array of
immune responses to malaria co-infections in murine
models that may explain why certain individuals develop
CM while others exhibit only minor symptoms in hu-
man malaria infections.
Conclusions
The results of this study demonstrate that changes in
parasite density, both worm loads and Plasmodium para-
site count, could modulate protection against ECM dur-
ing the S. japonicum-P. berghei-co-infection. Increased
cercariae co-infected with low density of P. berghei resulted
in higher protection against ECM, while co-infection with
higher density of P. berghei led to a converse result. Alter-
ations in the regulatory response appear to play a key role
in this adaptation.
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